Changes of T lymphocyte subsets after kidney transplantation according to induction immunosuppressants
Korean Journal of Transplantation · 2020
DOI: 10.4285/atw2020.op-1096 ↗At a glance
Journal article in Korean Journal of Transplantation, 2020. Written by Hyung Duk Kim and 4 co-authors.
Abstract (original language)
The aim of this study is to investigate the change of T cell subsets during early post-transplant period according to the type of induction therapy (anti-thymocyte globulin [ATG] vs. basiliximab).
Methods
We conducted prospective observational study for 174 patients who underwent kidney transplantation and in Seoul St. Mary's Hospital from May 2018 to January 2020. A baseline blood sample was collected within 5 days before the kidney transplant, and additional blood samples were collected and analyzed at 4 weeks and 12 weeks after the kidney transplant. Flow cytometric study of peripheral blood mononuclear cells was performed using anti-CD3, -CD4, -CD57, -CD127, -CD161, -CD45RA, and -CCR7 in order to analyze T cell subsets. We compared the change of each T cell subsets between patients who took ATG (n=61) and basiliximab (n=113).
Results
At baseline, all of the CD4+ and CD8+ T cell subsets did not show significant differences. However, changing pattern of T cell subsets showed significant difference according to the type of induction therapy at 4 weeks and 12 weeks after kidney transplantation. In the ATG group, at 4 weeks, the expression of CD4+CD161+, CD4+CD25+CD127low, and CD8+CD45RA+C-CR7-T cells increased, and CD8+CD28nullCD57+ T cells decreased. At week 12, CD4+CD161+, CD4+CD25+CD127low, CD8+C-D45RA+CCR7-, CD8+CD45RA-CCR7-T cells significantly increased and CD8+CCR7+ T cells decreased. In basiliximab group, CD8+CCR7+ T cell expression decreased and CD8+CD45RA-CCR7-T cell increased at 12 weeks compared to baseline.
Conclusions
In this study, we observed CD4+CD161+ and CD4+CD25+CD127low T cells activation and increase of CD8+C-D45RA+CCR7-T cells in patients with ATG induction in comparison with basiliximab. The correlation between T cell subset changes and clinical outcome could not be confirmed in our study. Further long-term study is required to determine the effect of T cell subsets changes on clinical outcomes.
Cite
APA
Kim, H. D., Bae, H., Yang, C. W., Oh, E., & Chung, B. H. (2020). Changes of T lymphocyte subsets after kidney transplantation according to induction immunosuppressants. Korean Journal of Transplantation. https://doi.org/10.4285/atw2020.op-1096
Vancouver
Kim HD, Bae H, Yang CW, Oh E, Chung BH. Changes of T lymphocyte subsets after kidney transplantation according to induction immunosuppressants. Korean Journal of Transplantation. 2020. doi:10.4285/atw2020.op-1096
BibTeX
@article{Kim2020,
author = {Kim, Hyung Duk and Bae, Hyunjoo and Yang, Chul Woo and Oh, Eun-Jee and Chung, Byung Ha},
title = {Changes of T lymphocyte subsets after kidney transplantation according to induction immunosuppressants},
journal = {Korean Journal of Transplantation},
year = {2020},
doi = {10.4285/atw2020.op-1096}
}
EUVIMED